Bio-Connect
Jurkat lysates probed with IL24 Polyclonal Antibody, Unconjugated (bs-7537R) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.
Jurkat lysates probed with IL24 Polyclonal Antibody, Unconjugated (bs-7537R) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.
Jurkat lysates probed with IL24 Polyclonal Antibody, Unconjugated (bs-7537R) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.

IL24 Polyclonal Antibody

BS-10576R
Bioss
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetIL24
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Bioss
  • Product Name
    IL24 Polyclonal Antibody
  • Delivery Days Customer
    16
  • Applications
    ImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
  • Applications Supplier
    WB(1:300-5000), ELISA(1:500-1000), IHC-P(1:200-400), IHC-F(1:100-500), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 ug/ul
  • Conjugate
    Unconjugated
  • Gene ID11009
  • Target name
    IL24
  • Target description
    interleukin 24
  • Target synonyms
    C49A, FISP, IL10B, MDA7, MOB5, ST16, interleukin-24, IL-4-induced secreted protein, melanocyte-associated Mda-7, melanoma differentiation-associated gene 7 protein, suppression of tumorigenicity 16 (melanoma differentiation)
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ13007
  • Protein Name
    Interleukin-24
  • Storage Instruction
    -20°C
  • UNSPSC
    12352203

References

  • Combination therapy with F5/35 fiber chimeric conditionally replicative adenoviruses expressing IL-24 enhances the antitumor effect of temozolomide against melanoma. Yang M et al., 2018 Dec, Cancer Med
    Read more
  • A conditionally replicating adenovirus expressing IL-24 acts synergistically with temozolomide to enhance apoptosis in melanoma cells in vitro. Liang Z et al., 2017 Jun, Oncol Lett
    Read more